What if you could repair broken genes? That is the question we ask ourselves at Editas Medicine. Were focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 (also known as Cas12a) genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for many diseases. Were looking for talented, dedicated, passionate people to join our team and help us pioneer this field and do big, bold things that have never been achieved before. Are you full of hope, possibilities, and a belief that, working together, we can truly revolutionize the development of medicines to help patients around the world? If the answer is yes, then Editas Medicine is the place for you.
Editas Medicine is seeking a motivated research associate to support the development and progression of a new class of cellular therapies based on CRISPR-Cas gene edited induced Pluripotent Stem Cells (iPSCs). This associate will work closely with the iPSC Biology Team Leader to culture, reprogram, differentiate and characterize iPSC cells for our immuno-oncology programs. Previous experience culturing iPSC or similarly complex cell models is desired.
Key Responsibilities & Accountabilities:
Knowledge, Skills & Capabilities:
Education & Relevant Work Experience: